Search Login Register

quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate (solifenacin) Summary

Description: used for overactive bladder syndrome

Also Known As: solifenacin; YM 905; YM905; quinuclidin-3'-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monohydrochloride; solifenacin succinate Show All >>

Networked: 230 relevant articles (48 outcomes, 79 trials/studies) for this Drug

Key Diseases for which quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate is Relevant

  1. Overactive Urinary Bladder (Overactive Bladder) : 34 outcomes 64 studies in 184 results
  2. Nocturia : 10 outcomes 5 studies in 17 results
  3. Urge Urinary Incontinence (Urge Incontinence) : 4 outcomes 5 studies in 22 results
  4. Urinary Incontinence : 3 outcomes 2 studies in 10 results
  5. Prostatic Hyperplasia (Benign Prostatic Hyperplasia) : 1 outcome 1 study in 10 results
Show All >>

Drugs Related to quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate

  1. tolterodine (Detrol)
  2. oxybutynin (Tavor)
  3. propiverine
  4. imidafenacin
  5. tamsulosin (Flomax)
  6. darifenacin
  7. Muscarinic Antagonists
  8. Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
  9. trospium chloride (Ceris)
  10. Carbon Monoxide
Show All >>

Therapies Related to quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate

  1. Stents
  2. Prostatectomy (Retropubic Prostatectomy)
  3. Aftercare (After-Treatment)
  4. Deep Brain Stimulation
  5. Continuous Positive Airway Pressure
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.